https://www.expresspharma.in/zydus-receives-tentative-approval-from-us-fda-for-empagliflozin-and-linagliptin-tablets/
Nov 28, 2025 - Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (US FDA) for Empagliflozin and Linagliptin tablets, 10...
us fdazydusreceivestentativeapproval
https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2023.1302265/full
Background: Right ventricular (RV) failure is the prime cause of death in patients with pulmonary arterial hypertension. Novel treatment strategies that prot...
right ventricularfrontierseffectsempagliflozinadaptation
https://www.ajmc.com/view/in-heart-failure-empagliflozin-equals-the-competition-and-benefits-sicker-patients
A new study shows that empagliflozin, the diabetes drug that set off a market frenzy 5 years ago, is on par with dapagliflozin for certain heart failure...
heart failurethe competitionempagliflozinequalsbenefits